Cover Image
市場調查報告書 - 226614

歐洲的生物後續品市場的分析

Analysis of European Biosimilars Market

出版商 Frost & Sullivan
出版日期 內容資訊 英文 223 Pages
價格
歐洲的生物後續品市場的分析 Analysis of European Biosimilars Market
出版日期: 2011年12月20日 內容資訊: 英文 223 Pages
簡介

本報告書內容包括:歐洲的生物後續品市場為焦點、歐洲的紅血球生成素(紅血球生成促進因素)、顆粒球型刺激因素、人體成長荷爾蒙等確立的市場、以及單株抗體、胰島素、及干擾素等新興市場為中心、市場的評價・分析、市場及技術趨勢的概括、市場中成功的策略提議之提示等、內容綱要摘記如下:

第1章 實施摘要

  • 歐洲的生物後續品(生物仿製藥)市場摘要
    • 實施摘要

第2章 生物後續品(生物仿製藥)市場

  • 生物後續品市場的介紹
    • 生物後續品市場的概要
    • 預測和趨勢:全球的生物後續品市場
    • 市場佔有率和競爭分析:全球的生物後續品市場

第3章 歐洲的生物後續品市場

  • 歐洲的生物後續品市場介紹
    • 歐洲的生物後續品市場概要
    • 課題、市場成長促進及阻礙因素
    • 預測和趨勢
    • 需求分析
    • 市場佔有率和競爭分析
    • 規範導覽
  • 歐洲的紅血球生成素(紅血球生成促進因素)生物後續品市場
    • 歐洲的紅血球生成素生物後續品市場概要
    • 預測和趨勢
    • 市場佔有率和競爭分析
    • 規範導覽
  • 歐洲的顆粒球型刺激因素生物後續品市場
    • 歐洲的顆粒球行型刺激因素生物後續品市場概要
    • 預測和趨勢
    • 市場佔有率和競爭分析
    • 規範導覽
  • 歐洲的人體成長荷爾蒙生物後續品市場
    • 歐洲的人體成長荷爾蒙生物後續品市場概要
    • 預測和趨勢
    • 市場佔有率和競爭分析
    • 規範導覽
  • 歐洲的單株抗體生物後續品市場
    • 歐洲的單株抗體生物後續品市場的概要
    • 市場分析
    • 規範導覽
  • 歐洲的胰島素生物後續品市場
    • 歐洲的胰島素生物後續品市場概要
    • 市場分析
    • 規範導覽
  • 歐洲的干擾素生物後續品市場
    • 歐洲的干擾素生物後續品市場概要
    • 市場分析
    • 規範導覽

第4章 歐洲的生物後續品市場的各地區分析

  • 生物後續品市場:英國
    • 英國的生物後續品市場的概要
    • 預測和趨勢
  • 生物後續品市場:德國
    • 德國的生物後續品市場的概要
    • 預測和趨勢
  • 生物後續品市場:法國
    • 法國的生物後續品市場概要
    • 預測和趨勢
  • 生物後續品市場:義大利
    • 義大利的生物後續品市場概要
    • 預測和趨勢
  • 生物後續品市場:西班牙
    • 西班牙的生物後續品市場概要
    • 預測和趨勢
  • 生物後續品市場:荷比盧
    • 荷比盧的生物後續品市場概要
    • 預測和趨勢
  • 生物後續品市場:北歐
    • 北歐的生物後續品市場概要
    • 預測和趨勢

第5章 產品的介紹

  • 生物後續品市場的產品
    • 產品的介紹:歐洲的生物後續品
    • 產品的介紹:生物製劑
    • 未來情況的分析

第6章 結論和策略的提議

  • 調查的結論和市場加入企業的策略提議
    • 結論和策略的提議
    • 連結

第7章 附錄

  • 檔案表
    • 決策支援檔案庫
    • 省略語
    • 市場工程學評價
目錄

Abstract

The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success of market participants. This study is focused on established segments in Europe including Erythropoietin, Granulocyte Colony Stimulating Factors, Human Growth Hormones and emerging segments including monoclonal antibodies, Insulin and interferon. The established market segments consist of products currently approved and marketed in Europe. New therapeutic classes of drugs are expected to be a major contributor in the emerging market segments.

Table of Contents

1. Executive Summary

Summary of European Biosimilars Market

  • Executive Summary

2. Total Biosimilars Market

Introduction to the Total Biosimilars Market

  • Total Biosimilars Market Overview
  • Forecast and Trends - Global Biosimilars Market
  • Market Share and Competitive Analysis - Global Biosimilars Market

3. European Biosimilars Market

Introduction to European Biosimilars Market

  • European Biosimilars Market Overview
  • Challenges; Drivers and Restraints - European Biosimilars Market
  • Forecast and Trends - European Biosimilars Market
  • Demand Analysis - European Biosimilars Market
  • Market Share and Competitive Analysis - European Biosimilars Market
  • Regulatory Guidelines - European Biosimilars Market

European Erythropoietin Biosimilars Market

  • European Erythropoietin Biosimilars Market Overview
  • Forecast and Trends - European Erythropoietin Biosimilars Market
  • Market Share and Competitive Analysis - European Erythropoietin Biosimilars Market
  • Regulatory Guidelines - European Erythropoietin Biosimilars Market

European Granulocyte Colony Stimulating Factors Biosimilars Market

  • European Granulocyte Colony Stimulating Factors Biosimilars Market Overview
  • Forecast and Trends - European Granulocyte Colony Stimulating Factors Biosimilars Market
  • Market Share and Competitive Analysis - European Granulocyte Colony Stimulating Factors Biosimilars Market
  • Regulatory Guidelines - European Granulocyte Colony Stimulating Factors Biosimilars Market

European Human Growth Hormone Biosimilars Market

  • European Human Growth Hormone Biosimilars Market Overview
  • Forecast and Trends - European Human Growth Hormone Biosimilars Market
  • Market Share and Competitive Analysis - European Human Growth Hormone Biosimilars Market
  • Regulatory Guidelines - European Human Growth Hormone Biosimilars Market

European Monoclonal Antibodies Biosimilars Market

  • European Monoclonal Antibodies Biosimilars Market Overview
  • Market Analysis - European Monoclonal Antibodies Biosimilars Market
  • Regulatory Guidelines - European Monoclonal Antibodies Biosimilars Market

European Insulin Biosimilars Market

  • European Insulin Biosimilars Market Overview
  • Market Analysis - European Insulin Biosimilars Market
  • Regulatory Guidelines - European Insulin Biosimilars Market

European Interferon Biosimilars Market

  • European Interferon Biosimilars Market Overview
  • Market Analysis - European Interferon Biosimilars Market
  • Regulatory Guidelines - European Interferon Biosimilars Market

4. Regional Analysis of European Biosimilars Market

Biosimilars Market - The United Kingdom

  • The United Kingdom Biosimilars Market Overview
  • Forecast and Trends - The United Kingdom Biosimilars Market

Biosimilars Market - Germany

  • Germany Biosimilars Market Overview
  • Forecast and Trends - Germany Biosimilars Market

Biosimilars Market - France

  • France Biosimilars Market Overview
  • Forecast and Trends - France Biosimilars Market

Biosimilars Market - Italy

  • Italy Biosimilars Market Overview
  • Forecast and Trends - Italy Biosimilars Market

Biosimilars Market - Spain

  • Spain Biosimilars Market Overview
  • Forecast and Trends - Spain Biosimilars Market

Biosimilars Market - Benelux

  • Benelux Biosimilars Market Overview
  • Forecast and Trends - Benelux Biosimilars Market

Biosimilars Market - Scandinavia

  • Scandinavia Biosimilars Market Overview
  • Forecast and Trends - Scandinavia Biosimilars Market

5. Product Profiling

Products in the Biosimilars Market

  • Product Profiling - Biosimilars in Europe
  • Product Profiling - Biologics
  • Future Landscape Analysis

6. Conclusions and Strategic Recommendations

Conclusions of the study and Strategic Recommendations for Market Participants

  • Conclusions and Strategic Recommendations
  • The Last Word

7. Appendix

Data Tables

  • Decision Support Databases
  • Abbreviations
  • Market Engineering Methodology
Back to Top